Blog    |    Careers
 
 
WHO WE ARE

QUANTUM REGULATORY WRITING AND CONSULTING is a full-service, international agency dedicated to one thing only – regulatory affairs and pharmacogivilance, particularly the preparation of regulatory documents. Because we live and breathe regulatory affairs and pharmacogivilance we understand the complexities of preparation, filing/ registration and post filing/ registration needs. By simplifying workflow and streamlining processes, we can help you get more out of your next product filing or registration and clinical studies supporting data. It’s time to stop throwing money at the problem and start putting brains over budget.


QUANTUM REGULATORY WRITING AND CONSULTING provides full, professional regulatory medical writing,pharmacogivilance and consulting services to the pharmaceutical, biotechnology, and CRO industries in the United States, Europe, Russia and CIS countries. Full life-cycle support of documents from preclinical reports to regulatory submission documentation is provided.


Pharmacogivilance documentation such as PSURs and risk management plans also form part of the exceptional regulatory affairs services that QUANTUM REGULATORY WRITING AND CONSULTING provides.


Headed by physician, attorney and medical writer Lev G. Fedyniak, MD, JD and his pharmacist wife Olga Fedyniak, QUANTUM REGULATORY WRITING AND CONSULTING is built on quality, value, and service. Helping you meet your submission goals is our primary objective. We understand the need to get things done right. Being responsive to the client's needs and delivering quality projects on time and on budget are our priorities..

Services offered provide significant benefits to our clients:
Exceptional document quality
  Exceptional document quality
Reduction in project backlog
More efficient management of internal resources and workload
Scientific expertise
Collaborative relationships
Personalized service
Consistent on-time delivery
Significant cost savings
More...
 
Latest News (Courtesy of Medical News Today )
 
What We Do?
Our services include, but are not limited to:
Clinical
Study protocols/ protocol amendments
Investigator brochures and updates
Informed Consents
Clinical study reports (CSRs) (Phases I to IV)
CTD clinical summaries and overviews
Clinical trial registry and database summaries
Quality control checks of clinical documentation
Integrated Summaries of Efficacy (ISE), Safety (ISS), and Immunogenicity (ISI)
Clinical trial authorizations/investigational new drug applications (INDs), amendments, annual safety reports, etc
New Drug Applications (NDAs) and Common
Technical Document (CTDs) clinical and preclinical sections (Modules 2.4, 2.5, 2.6, and 2.7) and 505(b)(2) Applications
Biologic License Application (BLA)
Investigational Medicinal Product Dossier (IMPD)
clinical sections
SAE Narratives
Non-clinical reports
Product labeling
Patient information
pharmacogivilance
Periodic Safety Update Report (PSURs)
Suspected Unexpected Serious Adverse Reaction (SUSARs)
Individual Case Safety Report (ICSRs)
Risk Managements Plans (RMPs)
  More..